Indication

Friedreich's ataxia

Friedreich's ataxia is a rare, inherited, progressive neurodegenerative disorder typically manifesting in late childhood or adolescence, though late-onset presentations can occur. Read more about Friedreich's ataxia

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Friedreich's ataxia therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Friedreich's ataxia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Friedreich's ataxia.

Friedreich's ataxia is a rare, inherited, progressive neurodegenerative disorder typically manifesting in late childhood or adolescence, though late-onset presentations can occur.

It is inherited in an autosomal recessive pattern, most commonly caused by an expanded GAA trinucleotide repeat in the *FXN* gene, which results in a deficiency of the mitochondrial protein frataxin, impaired iron homeostasis, and mitochondrial energy dysfunction.

The disease predominantly affects the central and peripheral nervous systems—specifically causing degeneration of the dorsal root ganglia, sensory peripheral nerves, spinal cord tracts, and cerebellum—as well as non-neurological tissues.

Hallmark clinical features include progressive gait and limb ataxia, loss of deep tendon reflexes, dysarthria, sensory neuropathy, hypertrophic cardiomyopathy, scoliosis, and an increased risk of diabetes mellitus.

Personalize your experience

Follow Friedreich's ataxia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it